Article
Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.
Circulation research - 17 Feb 2012
Fadini Gian Paolo, Losordo Douglas, Dimmeler Stefanie
Abstract excerpt
Diverse subsets of endothelial progenitor cells (EPCs) are used for the treatment of ischemic diseases in clinical trials, and circulating EPCs levels are considered as biomarkers for coronary and peripheral artery disease. However, despite significant steps forward in defining their potential for both therapeutic and diagnostic purposes, further progress has been mired by unresolved questions around the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
